Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Risk factors for acquisition of meningococcal carriage in the African meningitis belt.

Cooper LV, Robson A, Trotter CL, Aseffa A, Collard JM, Daugla DM, Diallo A, Hodgson A, Jusot JF, Omotara B, Sow S, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Chandramohan D, Borrow R, Maiden MCJ, Greenwood B, Stuart JM; MenAfriCar Consortium.

Trop Med Int Health. 2019 Apr;24(4):392-400. doi: 10.1111/tmi.13203. Epub 2019 Feb 6.

2.

Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt.

Diallo K, Coulibaly MD, Rebbetts LS, Harrison OB, Lucidarme J, Gamougam K, Tekletsion YK, Bugri A, Toure A, Issaka B, Dieng M, Trotter C, Collard JM, Sow SO, Wang X, Mayer LW, Borrow R, Greenwood BM, Maiden MCJ, Manigart O; MenAfriCar Consortium.

PLoS One. 2018 Dec 5;13(12):e0206453. doi: 10.1371/journal.pone.0206453. eCollection 2018.

3.

Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study.

Basta NE, Berthe A, Keita M, Onwuchekwa U, Tamboura B, Traore A, Hassan-King M, Manigart O, Nascimento M, Stuart JM, Trotter C, Blake J, Carr AD, Gray SJ, Newbold LS, Deng Y, Wolfson J, Halloran ME, Greenwood B, Borrow R, Sow SO.

J Infect. 2018 Feb;76(2):140-148. doi: 10.1016/j.jinf.2017.11.006. Epub 2017 Nov 29.

4.

Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt.

Cooper LV, Boukary RM, Aseffa A, Mihret W, Collard JM, Daugla D, Hodgson A, Sokhna C, Omotara B, Sow S, Quaye SL, Diallo K, Manigart O, Maiden MCJ, Findlow H, Borrow R, Stuart JM, Greenwood BM, Trotter CL.

PLoS One. 2017 Aug 10;12(8):e0182575. doi: 10.1371/journal.pone.0182575. eCollection 2017.

5.

Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.

Diallo K, Gamougam K, Daugla DM, Harrison OB, Bray JE, Caugant DA, Lucidarme J, Trotter CL, Hassan-King M, Stuart JM, Manigart O, Greenwood BM, Maiden MCJ.

BMC Genomics. 2017 May 22;18(1):398. doi: 10.1186/s12864-017-3789-0.

6.

Alternative Molecular Methods for Improved Detection of Meningococcal Carriage and Measurement of Bacterial Density.

Manigart O, Okeakpu J, Odutola A, Jarju S, Foster-Nyarko E, Diallo K, Roca A, Kampmann B, D'Alessandro U, Sow S, Antonio M, Maiden MJ, Borrow R, Stuart JM, Trotter CL, Greenwood BM.

J Clin Microbiol. 2016 Nov;54(11):2743-2748. Epub 2016 Aug 31.

7.

Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.

Manigart O, Trotter C, Findlow H, Aseffa A, Mihret W, Moti Demisse T, Yeshitela B, Osei I, Hodgson A, Quaye SL, Sow S, Coulibaly M, Diallo K, Traore A, Collard JM, Moustapha Boukary R, Djermakoye O, Mahamane AE, Jusot JF, Sokhna C, Alavo S, Doucoure S, Ba EH, Dieng M, Diallo A, Daugla DM, Omotara B, Chandramohan D, Hassan-King M, Nascimento M, Woukeu A, Borrow R, Stuart JM, Greenwood B.

PLoS One. 2016 Jul 5;11(7):e0158938. doi: 10.1371/journal.pone.0158938. eCollection 2016.

8.

Pharyngeal carriage of Neisseria species in the African meningitis belt.

Diallo K, Trotter C, Timbine Y, Tamboura B, Sow SO, Issaka B, Dano ID, Collard JM, Dieng M, Diallo A, Mihret A, Ali OA, Aseffa A, Quaye SL, Bugri A, Osei I, Gamougam K, Mbainadji L, Daugla DM, Gadzama G, Sambo ZB, Omotara BA, Bennett JS, Rebbetts LS, Watkins ER, Nascimento M, Woukeu A, Manigart O, Borrow R, Stuart JM, Greenwood BM, Maiden MCJ.

J Infect. 2016 Jun;72(6):667-677. doi: 10.1016/j.jinf.2016.03.010. Epub 2016 Mar 23.

9.

A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.

Manigart O, Trotter C, Findlow H, Assefa A, Mihret W, Moti Demisse T, Yeshitela B, Osei I, Hodgson A, Quaye SL, Sow S, Coulibaly M, Diallo K, Traore A, Collard JM, Moustapha Boukary R, Djermakoye O, Mahamane AE, Jusot JF, Sokhna C, Alavo S, Doucoure S, Ba el H, Dieng M, Diallo A, Daugla DM, Omotara B, Chandramohan D, Hassan-King M, Nascimento M, Woukeu A, Borrow R, Stuart JM, Greenwood B.

PLoS One. 2016 Feb 12;11(2):e0147928. doi: 10.1371/journal.pone.0147928. eCollection 2016. Erratum in: PLoS One. 2016;11(7):e0158938.

10.

Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali.

Basta NE, Borrow R, Berthe A, Onwuchekwa U, Dembélé AT, Almond R, Frankland S, Patel S, Wood D, Nascimento M, Manigart O, Trotter CL, Greenwood B, Sow SO.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S578-85. doi: 10.1093/cid/civ513.

11.

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.

Gamougam K, Daugla DM, Toralta J, Ngadoua C, Fermon F, Page AL, Djingarey MH, Caugant DA, Manigart O, Trotter CL, Stuart JM, Greenwood BM.

Emerg Infect Dis. 2015 Jan;21(1):115-8. doi: 10.3201/eid2101.140256.

12.

Methods for identifying Neisseria meningitidis carriers: a multi-center study in the African meningitis belt.

Basta NE, Stuart JM, Nascimento MC, Manigart O, Trotter C, Hassan-King M, Chandramohan D, Sow SO, Berthe A, Bedru A, Tekletsion YK, Collard JM, Jusot JF, Diallo A, Basséne H, Daugla DM, Gamougam K, Hodgson A, Forgor AA, Omotara BA, Gadzama GB, Watkins ER, Rebbetts LS, Diallo K, Weiss NS, Halloran ME, Maiden MC, Greenwood B.

PLoS One. 2013 Oct 23;8(10):e78336. doi: 10.1371/journal.pone.0078336. eCollection 2013.

13.

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L, Narbé M, Toralta J, Kodbesse B, Ngadoua C, Coldiron ME, Fermon F, Page AL, Djingarey MH, Hugonnet S, Harrison OB, Rebbetts LS, Tekletsion Y, Watkins ER, Hill D, Caugant DA, Chandramohan D, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Trotter C, Stuart JM, Maiden M, Greenwood BM.

Lancet. 2014 Jan 4;383(9911):40-47. doi: 10.1016/S0140-6736(13)61612-8. Epub 2013 Sep 12. Erratum in: Lancet. 2014 Jan 4;383(9911):30.

14.

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa, Altmann D, Aseffa A, Bash M, Basta N, Borrow R, Broome C, Caugant D, Clark T, Collard JM, Djingarey M, Goldblatt D, Greenwood B, Griffiths U, Hajjeh R, Hassan-King M, Hugonnet S, Kimball AM, LaForce M, MacLennan C, Maiden MC, Manigart O, Mayer L, Messonnier N, Moisi J, Moore K, Moto DD, Mueller J, Nascimento M, Obaro S, Ouedraogo R, Page AL, Perea W, Pluschke G, Preziosi MP, Sow S, Stephens D, Stuart J, Thomson M, Tiendrebeogo S, Trape JF, Vernet G.

Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27.

15.

A gp41-based heteroduplex mobility assay provides rapid and accurate assessment of intrasubtype epidemiological linkage in HIV type 1 heterosexual transmission Pairs.

Manigart O, Boeras DI, Karita E, Hawkins PA, Vwalika C, Makombe N, Mulenga J, Derdeyn CA, Allen S, Hunter E.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1745-55. doi: 10.1089/AID.2012.0023. Epub 2012 Jul 3.

16.

Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses.

Kraft CS, Basu D, Hawkins PA, Hraber PT, Chomba E, Mulenga J, Kilembe W, Khu NH, Derdeyn CA, Allen SA, Manigart O, Hunter E.

Retrovirology. 2012 Mar 20;9:22. doi: 10.1186/1742-4690-9-22.

17.

Altered vaginal microbiota are associated with perinatal mother-to-child transmission of HIV in African women from Burkina Faso.

Frank DN, Manigart O, Leroy V, Meda N, Valéa D, Zhang W, Dabis F, Pace NR, Van de Perre P, Janoff EN.

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):299-306. doi: 10.1097/QAI.0b013e31824e4bdb.

18.

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC.

J Virol. 2009 Jul;83(14):7337-48. doi: 10.1128/JVI.00110-09. Epub 2009 May 13.

19.

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, Anzala O, Jaoko W, Mutua G, Ruzagira E, Mulenga J, Sanders EJ, Mwangome M, Allen S, Bwanika A, Bahemuka U, Awuondo K, Omosa G, Farah B, Amornkul P, Birungi J, Yates S, Stoll-Johnson L, Gilmour J, Stevens G, Shutes E, Manigart O, Hughes P, Dally L, Scott J, Stevens W, Fast P, Kamali A.

PLoS One. 2009;4(2):e4401. doi: 10.1371/journal.pone.0004401. Epub 2009 Feb 6.

20.

Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1.

Haaland RE, Hawkins PA, Salazar-Gonzalez J, Johnson A, Tichacek A, Karita E, Manigart O, Mulenga J, Keele BF, Shaw GM, Hahn BH, Allen SA, Derdeyn CA, Hunter E.

PLoS Pathog. 2009 Jan;5(1):e1000274. doi: 10.1371/journal.ppat.1000274. Epub 2009 Jan 23.

21.

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.

Stevens W, Kamali A, Karita E, Anzala O, Sanders EJ, Jaoko W, Kaleebu P, Mulenga J, Dally L, Fast P, Gilmour J, Farah B, Birungi J, Hughes P, Manigart O, Stevens G, Yates S, Thomson H, von Lieven A, Krebs M, Price MA, Stoll-Johnson L, Ketter N.

PLoS One. 2008 Apr 30;3(4):e2043. doi: 10.1371/journal.pone.0002043.

22.

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, Manigart O, Mulenga J, Anderson JA, Swanstrom R, Haynes BF, Athreya GS, Korber BT, Sharp PM, Shaw GM, Hahn BH.

J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07. Epub 2008 Feb 6.

23.

Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission.

Manigart O, Crepin M, Leroy V, Meda N, Valea D, Janoff EN, Rouet F, Dequae-Merchadoux L, Dabis F, Rouzioux C, Van de Perre P; Diminution de la Transmission Mere-Enfant Study Group.

J Infect Dis. 2004 Oct 15;190(8):1422-8. Epub 2004 Sep 9.

PMID:
15378434
24.

HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure.

Manigart O, Courgnaud V, Sanou O, Valéa D, Nagot N, Meda N, Delaporte E, Peeters M, Van de Perre P.

AIDS. 2004 Aug 20;18(12):1645-51.

PMID:
15280775
25.

Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa.

Meda N, Leroy V, Viho I, Msellati P, Yaro S, Mandelbrot L, Montcho C, Manigart O, Dabis F; DITRAME-ANRS 049 Study Group.

AIDS. 2002 Nov 22;16(17):2323-8.

PMID:
12441805
26.

18-Month mortality and perinatal exposure to zidovudine in West Africa.

Dabis F, Elenga N, Meda N, Leroy V, Viho I, Manigart O, Dequae-Merchadou L, Msellati P, Sombie I; DITRAME Study Group.

AIDS. 2001 Apr 13;15(6):771-9.

PMID:
11371692
27.

Long-term reduction of HIV transmission from mother to breastfed child by antiretroviral agents: are more drugs better than less?

Van de Perre P, Manigart O, Meda N.

AIDS. 2001 Mar 30;15(5):658-9. No abstract available.

PMID:
11317009
28.

Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.

Leroy V, Montcho C, Manigart O, Van de Perre P, Dabis F, Msellati P, Meda N, You B, Simonon A, Rouzioux C; DITRAME Study Group.

AIDS. 2001 Mar 9;15(4):517-22.

PMID:
11242149
29.

Maternal vitamin A status and mother-to-child transmission of HIV in West Africa. DITRAME Study Group.

Castetbon K, Manigart O, Bonard D, Thomas MJ, Dumon MF, Malvy D, Van de Perre P, Dabis F.

AIDS. 2000 May 5;14(7):908-10. No abstract available.

30.

Diversity of HIV-1 genetic subtypes in France, in the context of mother-to-child transmission. The French Pediatric Cohort Study Group.

Chaix ML, Manigart O, Letourneur F, Burgard M, Mayaux MJ, Rouzioux C.

AIDS. 2000 Feb 18;14(3):327-8. No abstract available.

PMID:
10716512
31.

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.

Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, Leroy V, Simonon A, Cartoux M, Combe P, Ouangré A, Ramon R, Ky-Zerbo O, Montcho C, Salamon R, Rouzioux C, Van de Perre P, Mandelbrot L.

Lancet. 1999 Mar 6;353(9155):786-92.

PMID:
10459959
32.

Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.

Buseyne F, Chaix ML, Fleury B, Manigart O, Burgard M, Blanche S, Rouzioux C, Rivière Y.

Virology. 1998 Oct 25;250(2):316-24. Erratum in: Virology. 2008 Mar 15;372(2):457. Manigard, O [corrected to Manigart, O].

Supplemental Content

Loading ...
Support Center